Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Cancer Cachexia Market to Grow at 4.9% CAGR to Reach US$ 2.51 Bn by 2025

Press release Description

Albany, New York, April 27, 2018: A new business intelligence study titled, “Cancer Cachexia Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has been added to the vast research repository of Market Research Reports Search Engine (MRRSE). According to the research study, the global cancer cachexia market is likely to witness a CAGR of 4.9% during the assessment period 2017-2025, and reach a valuation of over US$ 2.51 Bn.

The research study the cancer cachexia market in detail, and offers an analysis and forecast on the key factors that are likely to boost this market during the assessment period. The key qualitative factors, including the drivers, restraints, opportunities, and trends prevailing in the market have been studied in detail in the report. The market research study also offers information on the financial structure, product strategy, and business scenario of some of the leading companies in the market.

According to the report, the growth of the global cancer cachexia market is likely to increase at a steady clip on account of growing prevalence of cancer cachexia and rising awareness among end-users on the effective treatment options available to treat this disease. The prevalence of cancer cachexia is around 1% of the total population – as awareness is increase, healthcare providers and patients are adopting novel methods of treatment. These factors are likely to provide an impetus to the growth of the cancer cachexia market during the assessment period.

The promising clinical pipeline and regulatory approvals are likely to open up new avenues of growth for manufacturers. In addition to developed countries, the market is also likely to witness steady growth in developing countries, especially ASEAN, South Africa, and Brazil. The growing emphasis of developing countries to boost their healthcare infrastructure, and offer quality care and treatment solutions to their citizens is likely to provide an impetus to growth during the assessment period.

Highlighting the region analysis in the market, the report predicts that North America is likely to remain the largest market for cancer cachexia during the assessment period. The innovation and growth in North America is likely to remain concentrated in the US, whereas Canada is also likely to offer growth opportunities to manufacturers. According to the report, North America is likely to account for 40% revenue share of the market. In Addition to North America, Asia Pacific is likely to emerge as one of the most lucrative countries for stakeholders in this market.

The research study also highlights the product and business strategies of some of the leading players in the market. The key companies profiled in the report include Zentaris Inc., Eli Lilly and Co., Aphios Corp., Alder BioPharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc., Bristol-Myers Squibb Co., Novartis AG, and XBiotech Inc.

Browse Full Global Cancer Cachexia Market Report with TOC : https://www.mrrse.com/cancer-cachexia-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com